Xilio Development
Price & Volume
Stats
See more52W Range | $6.46-$16.52 |
Market Cap | $49.1M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $43.7M |
Revenue Growth (YoY) | 693.9% |
Gross Profit (12 Mos) | $43.7M |
Diluted EPS | -$58.66 |
News
See moreYahoo Finance • 4 days ago
Most and least shorted small-to-mid-cap stocks
Yahoo Finance • 2 months ago
Xilio Therapeutics Announces Pricing of Underwritten Offering
Yahoo Finance • 5 months ago
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2025 Financial Results
About
CEO | Dr. Rene Russo BCPS, Pharm.D. |
CFO | Mr. Christopher Frankenfield |
Address | 828 Winter Street, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 76 |
